TrialNature medicine2025

Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial.

Brian G Rash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.